Plunkett Research Online: Spark Therapeutics Inc

SPARK THERAPEUTICS INC (ONCE:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Spark Therapeutics, Inc. is a leader in the field of gene therapy for the treatment of debilitating genetic disease by developing one-time, life-altering drugs. The company’s goal is to overcome the effects of a malfunctioning, disease-causing gene. Spark’s most advanced product is LUXTURNA (voret.....



Spark Therapeutics Inc
Ticker: ONCE
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 888 772-7560
Fax:
Address: 3737 Market Street
Suite 1300
Philadelphia, PA 19104 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Gene Therapy Preparations Manufacturing
ContactsDescription
Jeffrey MarrazzoCEO/Co-Founder/Director
Stephen WebsterCFO/Chief Accounting Officer
See More
Spark Therapeutics, Inc. is a leader in the field of gene therapy for the treatment of debilitating genetic disease by developing one-time, life-altering drugs. The company’s goal is to overcome the effects of a malfunctioning, disease-causing gene. Spark’s most advanced product is LUXTURNA (voret.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
LUXTURNA
SPK-7001
SPK-9001
SPK-FIX
SPK-8011
SPK-FVIII
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: